critique

# Critical Evaluation of Hypotheses on B Cell Tolerance to AQP4

---

## Hypothesis 1: Receptor Editing via RAG-Mediated V(D)J Recombination

### Strongest Specific Weakness: Anatomical Paradox of Central Tolerance

The hypothesis invokes central tolerance mechanisms (bone marrow receptor editing) without addressing a fundamental prerequisite: *how do developing B cells in the bone marrow encounter the AQP4 autoantigen?* AQP4 is predominantly expressed in the central nervous system—specifically in astrocytic foot processes at the blood-brain barrier, optic nerves, and spinal cord (PMID: 12401984). There is no established mechanism for CNS antigens to access the bone marrow microenvironment at sufficient concentrations to tolerize developing B cells. This is not a peripheral antigen like DNA or insulin with known splenic or thymic cross-presentation; AQP4 is anatomically sequestered.

Central tolerance requires cognate antigen recognition in the bone marrow. Without AQP4 presence or transport there, receptor editing of AQP4-specific B cells cannot occur in situ. An alternative model—peripheral tolerance of naïve AQP4-specific B cells—must explain the observed tolerance state.

### Counter-Evidence and Complications

1. **RAG re-expression in mature/immature B cells is not well-established**: While receptor editing occurs in ~25% of autoreactive specificities (as cited), this primarily occurs at the pre-B cell stage during normal development. The assertion that *already-formed* immature B cells with AQP4-reactivity can reactivate RAG1/2 for secondary V(D)J